| __timestamp | Gilead Sciences, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 21102000000 | 580006000 |
| Thursday, January 1, 2015 | 28633000000 | 676585000 |
| Friday, January 1, 2016 | 26129000000 | 778966000 |
| Sunday, January 1, 2017 | 21736000000 | 671251000 |
| Monday, January 1, 2018 | 17274000000 | 463508000 |
| Tuesday, January 1, 2019 | 17774000000 | 445724000 |
| Wednesday, January 1, 2020 | 20117000000 | 399725000 |
| Friday, January 1, 2021 | 20704000000 | 296656000 |
| Saturday, January 1, 2022 | 21624000000 | 293122000 |
| Sunday, January 1, 2023 | 20618000000 | 268323000 |
| Monday, January 1, 2024 | 78200000 | 304979000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, Gilead Sciences, Inc. and Taro Pharmaceutical Industries Ltd. have been key players. From 2014 to 2023, Gilead consistently outperformed Taro in terms of gross profit. Gilead's peak was in 2015, with a gross profit nearly 50% higher than its average over the decade. In contrast, Taro's highest gross profit was in 2016, yet it was only about 3% of Gilead's peak. Despite fluctuations, Gilead maintained a robust average gross profit, approximately 45 times greater than Taro's. However, Taro showed resilience, maintaining a steady performance with minimal decline. The data for 2024 is incomplete, but the trends suggest Gilead's dominance in gross profit generation is likely to continue. This analysis highlights the significant disparity in financial performance between these two pharmaceutical giants over the past decade.
Johnson & Johnson vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: AstraZeneca PLC vs Gilead Sciences, Inc.
Gross Profit Trends Compared: Amgen Inc. vs Gilead Sciences, Inc.
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Gilead Sciences, Inc. and Alnylam Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Gilead Sciences, Inc. and Exelixis, Inc. Trends
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or Alkermes plc
Gilead Sciences, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Genmab A/S and Taro Pharmaceutical Industries Ltd. Trends
Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Bausch Health Companies Inc. vs Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Taro Pharmaceutical Industries Ltd. and MiMedx Group, Inc.